VITROLIFE A/S: Financial statements 2012
CVR: 27406793
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
VITROLIFE A/S (CVR 27406793) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 23,954,175 and a net result of DKK -14,069,985. Equity in the 2012 report amounted to DKK 78,123,633. The solvency ratio was 67.5%.
- Gross Profit
- DKK 23,954,175
- Profit/Loss
- DKK -14,069,985
- Equity
- DKK 78,123,633
- Total Assets
- DKK 115,777,312
Official annual report
Keep an eye on VITROLIFE A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of November 23, 2012, Søren Nielsen has joined the board of directors of VITROLIFE A/S.
As of November 23, 2012, Kirsten Marie Jakobsen has left the board of directors of VITROLIFE A/S.
As of November 23, 2012, Manuel de la Llave has left the board of directors of VITROLIFE A/S.
As of May 23, 2012, Lars Rabe Tønnesen has joined the board of directors of VITROLIFE A/S.
As of May 23, 2012, Hans Jørgen Angaard Madsen has left the board of directors of VITROLIFE A/S.
About VITROLIFE A/S
VITROLIFE A/S is a Danish company of the type Aktieselskab based in Viby J, founded in 2003. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named UNISENSE FERTILITECH A/S and UNISENSE FERTILITECH ApS. The management consists of Dag Erik Rickard Ericsson. The board consists of Sten Jakob Hedén (chair), Dag Erik Rickard Ericsson and Tom Faes. The company is owned by Vitrolife AB. The company has 114 employees (2026). In 2025, the company reported a gross profit of DKK 228,406,323 and a net result of DKK 110,485,853 compared with DKK 130,285,262 the year before. Equity in the 2025 report amounted to DKK 327,839,900.